Pre-Op Dual Checkpoint Blockade Promising for Certain Bladder Cancers

(MedPage Today) -- Neoadjuvant dual checkpoint blockade had a tolerable safety profile and encouraging efficacy in patients with cisplatin-ineligible high-risk urothelial carcinoma, according to the results of a nonrandomized pilot study.
Among...